Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Analyst Confidence Surges for US Foods Stock

Dieter Jaworski by Dieter Jaworski
September 8, 2025
in Analysis, Consumer & Luxury, Value & Growth
0
US Foods Stock
0
SHARES
183
VIEWS
Share on FacebookShare on Twitter

A wave of upward revisions from top financial institutions is bolstering the outlook for US Foods Holding Corp. This shift in sentiment is led by UBS, which has significantly raised its price target from $84 to $96. The consensus among ten covering analysts now points to an average target of $88.20, suggesting a potential upside of more than 13% from recent trading levels.

The company’s strong second-quarter 2025 earnings, reported on August 7th, serve as the foundation for this renewed optimism. US Foods posted adjusted earnings per share of $1.19, solidly exceeding the $1.14 consensus estimate. While net sales saw a 3.8% increase to $10.08 billion, this figure came in just shy of market expectations.

Key Developments:
* Wall Street Zen: Upgrade from “Buy” to “Strong Buy”
* UBS Group: Price target raised to $96
* Q2 Adjusted EPS: $1.19 (Estimate: $1.14)
* Median Price Target: $90
* Upcoming Event: CFO appearance at Piper Sandler Conference on September 10

This positive reassessment extends beyond a single firm. Other major banks, including Piper Sandler, Wells Fargo, and Morgan Stanley, have also lifted their price objectives for the food distributor’s shares. The median price target from a broader set of twenty analysts sits at $90, with the most bullish projections reaching as high as $103.

Should investors sell immediately? Or is it worth buying US Foods?

Institutional investment activity further underscores this confidence. Several major funds increased their stakes in US Foods during the second quarter. Benjamin Edwards Inc. grew its position by 3.3%, while Securian Asset Management and Archer Investment Corp. also added to their holdings. Conversely, Executive Vice President Dirk J. Locascio sold 7,500 shares in July at an average price of $80 per share—a transaction closely monitored by market participants.

Trading at $77.91 as of the September 5th close, the stock is positioned above its 200-day moving average of $73.29 but slightly below its 50-day average of $79.92. With a price-to-earnings ratio of 33.28 and a market capitalization of $17.54 billion, the valuation remains ambitious.

Market attention now turns to an upcoming presentation by CFO Dirk Locascio at the Piper Sandler Growth Frontiers Conference on September 10th. This appearance is anticipated to provide further clarity on the company’s strategic direction and operational plans moving forward.

Ad

US Foods Stock: Buy or Sell?! New US Foods Analysis from February 7 delivers the answer:

The latest US Foods figures speak for themselves: Urgent action needed for US Foods investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

US Foods: Buy or sell? Read more here...

Tags: US Foods
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Bank7 Stock
Analysis

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

February 7, 2026
Next Post
Emerson Electric Stock

Emerson Electric Shares Lag Behind Broader Market Rally

Natera Stock

Natera's Stock Dilemma: Record Revenue Meets Insider Selling Spree

Biogen Stock

Biogen's Strategic Pivot Faces Critical Test with New Alzheimer's Therapy

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com